Details for Patent: 12,653,824
Which drugs does patent 12,653,824 protect, and when does it expire?
Patent 12,653,824 protects TYRVAYA and is included in one NDA.
This patent has forty-three patent family members in twenty countries.
Summary for Patent: 12,653,824
| Title: | Compositions and use of varenicline for treating dry eye |
| Abstract: | Described herein are methods and pharmaceutical formulations for treating dry eye disease. |
| Inventor(s): | Douglas Michael Ackermann, JR., James LOUDIN, Kenneth J. Mandell |
| Assignee: | Oyster Point Pharma Inc |
| Application Number: | US19/169,836 |
|
Patent Claim Types: see list of patent claims | Formulation; Compound; |
Drugs Protected by US Patent 12,653,824
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Oyster Point Pharma | TYRVAYA | varenicline tartrate | SPRAY;NASAL | 213978-001 | Oct 15, 2021 | RX | Yes | Yes | ⤷ Start Trial | ⤷ Start Trial | Y | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 12,653,824
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2015336216 | ⤷ Start Trial | |||
| Australia | 2020213351 | ⤷ Start Trial | |||
| Brazil | 112017008097 | ⤷ Start Trial | |||
| Brazil | 122022025737 | ⤷ Start Trial | |||
| Canada | 2965129 | ⤷ Start Trial | |||
| China | 107106542 | ⤷ Start Trial | |||
| China | 111956650 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
